銘利達(301268.SZ):目前公司製造設備和能力是充足的
格隆匯11月9日丨有投資者於投資者互動平台向銘利達(301268.SZ)提問,“請問公司有人形機器人方面的佈局嗎?公司設備及研發能力具備這方面的能力是嗎?”,公司回覆稱,公司主要業務領域是精密結構件,包括壓鑄、注塑以及型材衝壓等,無論壓鑄、注塑還是型材衝壓,在不同製造工藝上,主要的設備是通用的,如壓鑄機、注塑機、CNC、清洗,目前公司製造設備和能力是充足的。關於人形機器人應用領域,公司一直保持持續的關注,隨着規模商業化應用的逐步擴展,公司也會考慮介入該應用領域。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.